Hearing aid trial periods: Audiologists’ thoughts and practices in South Africa
Angie Heliopoulos and
Nomfundo Moroe
PLOS Global Public Health, 2023, vol. 3, issue 11, 1-16
Abstract:
The process of adjusting and becoming accustomed to hearing aids may be best facilitated by providing a hearing aid trial period. Globally, there are no standardised frameworks or regulations on the recommended hearing aid trial period. The main purpose of this study was to explore audiologists’ hearing aid trialing practices. A cross sectional study employed a quantitative, descriptive design to formulate the study. Ninety-five audiologists’ were recruited by means of a purposive sampling strategy. Data were collected through the use of an online survey via Google forms. A pilot study was conducted prior to the commencement of the main study in order to ensure reliability of the main study. The results indicated that two weeks was the most recommended duration of a trial period from audiologists’. Majority of audiologists’ (72.63%) offer hearing aid trials to their patients. Most audiologists’ who offer hearing aid trials choose to trial their patients with two different hearing aids. Findings revealed a need for trialing periods to become standard practice by audiologists’ when fitting hearing aids. Not enough audiologists’ are providing this service.
Date: 2023
References: Add references at CitEc
Citations:
Downloads: (external link)
https://journals.plos.org/globalpublichealth/artic ... journal.pgph.0002552 (text/html)
https://journals.plos.org/globalpublichealth/artic ... 02552&type=printable (application/pdf)
Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.
Export reference: BibTeX
RIS (EndNote, ProCite, RefMan)
HTML/Text
Persistent link: https://EconPapers.repec.org/RePEc:plo:pgph00:0002552
DOI: 10.1371/journal.pgph.0002552
Access Statistics for this article
More articles in PLOS Global Public Health from Public Library of Science
Bibliographic data for series maintained by globalpubhealth ().